During the past decade, Charleston Oncology - Saint Francis conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 12 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charleston Oncology - Saint Francis" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charleston Oncology - Saint Francis" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Charleston Oncology - Saint Francis" are "Recurrent Breast Carcinoma" (3 trials), "Recurrent Melanoma" (3 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials) and "Stage III Cutaneous Melanoma AJCC v7" (2 trials). Many other conditions were trialed in "Charleston Oncology - Saint Francis" in a lesser frequency.

Most popular intervention types in "Charleston Oncology - Saint Francis" are "Drug" (17 trials), "Other" (15 trials), "Biological" (9 trials), "Procedure" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Quality-of-Life Assessment" (7 trials), "Computed Tomography" (4 trials), "Placebo Administration" (4 trials) and "Trastuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Charleston Oncology - Saint Francis" are 16 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Charleston Oncology - Saint Francis". undefined are not yet recruiting, 3 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Charleston Oncology - Saint Francis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charleston Oncology - Saint Francis, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".